We are live on
!
Find out more
MS
Maven Securities Portfolio holdings
AUM
$5.2B
1-Year Est. Return
44.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.1%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
-$248M
(-17%)
Cap. Flow
-$400M
Cap. Flow
% of AUM
-32.99%
Top 10 Holdings %
Top 10 Hldgs %
23.94%
Holding
810
New
297
Increased
109
Reduced
151
Closed
223
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caesars Entertainment
CZR
|
+$16.2M |
| 2 |
Adaptive Biotechnologies
ADPT
|
+$15.8M |
| 3 |
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
|
+$12.7M |
| 4 |
NBL
Noble Energy, Inc.
NBL
|
+$11.9M |
| 5 |
Simulations Plus
SLP
|
+$10.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agios Pharmaceuticals
AGIO
|
+$16M |
| 2 |
BLUE
bluebird bio
BLUE
|
+$12.2M |
| 3 |
BHP
BHP
|
+$10.7M |
| 4 |
Allogene Therapeutics
ALLO
|
+$8.56M |
| 5 |
Willis Towers Watson
WTW
|
+$6.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.03% |
| 2 | Technology | 7.51% |
| 3 | Consumer Discretionary | 5.23% |
| 4 | Financials | 5.2% |
| 5 | Industrials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
526
CALL
Marsh
MRSH
$86.3B
| $229K | 0.02% |
+2,000
| New | +$229K |
|
527
PUT
TJX Companies
TJX
$170B
| $229K | 0.02% |
+4,100
| New | +$221K |
|
528
PUT
Dominion Energy
D
$62.5B
| $228K | 0.02% |
2,900
| – | – |
|
529
Charles River Laboratories
CRL
$10.9B
| $227K | 0.02% |
+1,000
| New | +$208K |
|
530
PUT
Southern Company
SO
$110B
| $227K | 0.02% |
4,200
-1,100
| -21% | -$58.8K |
|
531
Kymera Therapeutics
KYMR
$9.1B
| $226K | 0.02% |
+7,143
| New | +$218K |
|
532
CALL
Blackrock
BLK
$164B
| $225K | 0.02% |
400
-800
| -67% | -$456K |
|
533
CALL
Nucor
NUE
$56.4B
| $224K | 0.02% |
+5,000
| New | +$221K |
|
534
Ferrari
RACE
$63.3B
| $224K | 0.02% |
+1,216
| New | +$226K |
|
535
IBEX
IBEX
$448M
| $223K | 0.02% |
+15,000
| New | +$203K |
|
536
CALL
Applied Materials
AMAT
$426B
| $221K | 0.02% |
3,700
-27,400
| -88% | -$1.69M |
|
537
CALL
WisdomTree US Total Dividend Fund
DTD
$1.65B
| $221K | 0.02% |
+9,000
| New | +$423K |
|
538
Carvana
CVNA
$43.3B
| $219K | 0.02% |
+5,000
| New | +$177K |
|
539
PUT
CME Group
CME
$92.2B
| $218K | 0.02% |
+1,300
| New | +$219K |
|
540
PUT
Mercado Libre
MELI
$91.3B
| $218K | 0.02% |
200
-700
| -78% | -$760K |
|
|
FRC
541
PUT
DELISTED
First Republic Bank
FRC
| $218K | 0.02% |
2,000
| – | – |
|
542
PUT
Truist Financial
TFC
$63.2B
| $217K | 0.02% |
5,800
-3,500
| -38% | -$132K |
|
543
CALL
Exelon
EXC
$48.6B
| $214K | 0.02% |
8,412
| – | – |
|
544
Dyne Therapeutics
DYN
$4.04B
| $212K | 0.02% |
+10,600
| New | +$233K |
|
545
PUT
Cincinnati Financial
CINF
$28.3B
| $210K | 0.02% |
+2,700
| New | +$209K |
|
546
Philip Morris
PM
$301B
| $209K | 0.02% |
+2,796
| New | +$216K |
|
547
Delta Air Lines
DAL
$55.9B
| $208K | 0.02% |
+6,655
| New | +$192K |
|
548
Eaton
ETN
$157B
| $208K | 0.02% |
+2,039
| New | +$199K |
|
|
LONA
549
LeonaBio Inc
LONA
$69.4M
| $207K | 0.02% |
+1,250
| New | +$209K |
|
550
PUT
DuPont de Nemours
DD
$18.6B
| $206K | 0.02% |
+2,948
| New | +$207K |
|
Similar funds
AUB
AP
KACA
DDC
MIM
AAI
SDIC
SCM
Maven Securities's Q3 2020 Portfolio in Review
As of Q3 2020, Maven Securities held 810 positions worth $1.21B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Maven Securities withdrew a net $400M in Q3 2020, closing 223 positions and reducing 151 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $16M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Maven Securities opened a new position in Adaptive Biotechnologies worth $18M.
- Maven Securities's largest Q3 2020 buy was Adaptive Biotechnologies: 375,000 shares worth $18M.
- Maven Securities added most to Caesars Entertainment in Q3 2020, an estimated $16.2M increase.
- Maven Securities's biggest Q3 2020 reduction was BHP, cutting an estimated $10.7M.
- Maven Securities fully exited Agios Pharmaceuticals in Q3 2020, selling an estimated $16M.
- Maven Securities's ten largest holdings make up 24% of its $1.21B portfolio in Q3 2020.
- Maven Securities opened 297 new positions and closed 223 in Q3 2020.
- Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.21B.
Based on Maven Securities's 13F filing for Q3 2020, filed 13 Nov 2020.